No. 1; Abstract Category: Leukemia Abstract Title: Erythroleukemia with hemophagocytosis Full Name: Tummidi Santosh E-mail: born_vss@yahoo.co.in Institution/Company: MKCG Medical College, India Other Authors: Manoj Kumar Patro, Jayanti Naik, Bodhisatwa Behera, Atanu Kumar Bal, Anita Choudhary, Swayamprabha Paradhan, Debi Prasad Mishra Abstract Details: Background: Acute myeloid leukemia (AML) M6 is uncommon, accounting for 1% of all acute leukemic cases and 3 – 4% of AML. Di Gulielmo first reported the original case of acute erythroid leukemia in 1917. The following are definitions according to the World Health Organization (WHO) 2008 classification: pure erythroid leukemia (French – American – British [FAB] subtype b): erythroblasts 80% of bone marrow nucleated cells with no evidence of a significant myeloblastic component; erythroid leukemia (erythroid/myeloid FAB subtype a): 50% erythroid precursors in bone marrow (BM) nucleated cells, 20% myeloblasts in non-erythroid cells. Hemophagocytosis has no known association with AML. The rarity of association of hemophagocytosis with erythroleukemia has prompted us to report this case. Case report: A 36-year-old Hindu female presented with fatigue, generalized body aches and pain for the last 6 weeks. The patient ’ s peripheral blood showed a leukoerythroblastic blood picture with hemoglobin (Hb) of 3.4 g/dL, total leukocyte count (TLC) 6400/mm 3 and platelet count of 89 000/ mm 3 . Bone marrow aspirate and biopsy revealed a markedly hypercellular bone marrow replaced by erythroid precursors, representing approximately 53% of the marrow cells and myeloblasts representing 49% of non-erythroid cells. The erythroid precursors displayed dysplastic morphology, including megaloblastic features, multinucleation, nuclear lobation and budding, and they were periodic acid – Schiff (PAS)-positive. The presence of hemophagocytosis was noted. Immunohistochemistry (IHC) showed positivity for GLY-A and CMPO, so a diagnosis of acute erythroid leukemia (erythroid/ myeloid) with hemophagocytosis was made.Details: Background: Acute myeloid leukemia (AML) M6 is uncommon, accounting for 1% of all acute leukemic cases and 3 – 4% of AML. Di Gulielmo first reported the original case of acute erythroid leukemia in 1917. The following are definitions according to the World Health Organization (WHO) 2008 classification: pure erythroid leukemia (French – American – British [FAB] subtype b): erythroblasts 80% of bone marrow nucleated cells with no evidence of a significant myeloblastic component; erythroid leukemia (erythroid/myeloid FAB subtype a): 50% erythroid precursors in bone marrow (BM) nucleated cells, 20% myeloblasts in non-erythroid cells. Hemophagocytosis has no known association with AML. The rarity of association of hemophagocytosis with erythroleukemia has prompted us to report this case. Case report: A 36-year-old Hindu female presented with fatigue, generalized body aches and pain for the last 6 weeks. The patient ’ s peripheral blood showed a leukoerythroblastic blood picture with hemoglobin (Hb) of 3.4 g/dL, total leukocyte count (TLC) 6400/mm 3 and platelet count of 89 000/ mm 3 . Bone marrow aspirate and biopsy revealed a markedly hypercellular bone marrow replaced by erythroid precursors, representing approximately 53% of the marrow cells and myeloblasts representing 49% of non-erythroid cells. The erythroid precursors displayed dysplastic morphology, including megaloblastic features, multinucleation, nuclear lobation and budding, and they were periodic acid – Schiff (PAS)-positive. The presence of hemophagocytosis was noted. Immunohistochemistry (IHC) showed positivity for GLY-A and CMPO, so a diagnosis of acute erythroid leukemia (erythroid/ myeloid) with hemophagocytosis was made.
[1]
M. Heyman,et al.
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia – a multicentre study from the Nordic Society of Paediatric Haematology and Oncology
,
2015,
British journal of haematology.
[2]
D. Sutherland,et al.
Use of a FLAER-based WBC assay in the primary screening of PNH clones.
,
2009,
American journal of clinical pathology.
[3]
Shailesh R. Singi,et al.
Transfusion-associated graft-versus-host disease in an immunocompetent individual
,
2006
.
[4]
D. Reinhardt,et al.
Immunophenotype of Down Syndrome Acute Myeloid Leukemia and Transient Myeloproliferative Disease Differs Significantly from Other Diseases with Morphologically Identical or Similar Blasts
,
2005,
Klinische Padiatrie.
[5]
G. Gustafsson,et al.
Acute leukaemia in children with Down syndrome: a population‐based Nordic study
,
2005,
British journal of haematology.
[6]
R. Paredes-Aguilera,et al.
Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children
,
2003,
American journal of hematology.
[7]
G. Flandrin,et al.
Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC)
,
2003,
Leukemia & lymphoma.
[8]
C. Parshuram,et al.
Transfusion-associated graft versus host disease
,
2002,
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[9]
K. C. Anderson,et al.
Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients.
,
1996,
Transfusion medicine reviews.
[10]
T. Lion,et al.
The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children
,
1992
.